Dan Watkins, Ph.D.

CEO Mercury Data Science (MDS). Also, Partner/Co-Founder of Mercury Fund where I am an investor in life sciences and industrial sectors with a focus on AI/ML differentiated businesses. Representative portfolio companies include Benson Hill (NYSE: BHIL), Confluence Life Sciences (acquired by ACRS), and Olea Edge Analytics. Former director and founding CEO of Courier Therapeutics (acquired by Valo Health for over $500M in cash and milestone payments). Co-Founder of the Rice Alliance. PhD in Materials Science from Carnegie Mellon University and BS in Materials Science from Rice University.